Nucleo Research, Inc.

–/10Traction

Nucleo provides automated AI technology to streamline clinical workflows in oncology care using CT scan analysis. The platform offers automatic quantification of body composition, precise tumor lesion sizing, and lesion classification based on RECIST criteria. This automation accelerates analysis compared to manual segmentation, improving consistency in diagnostic imaging review.

HQ unknown

3300+ followers

Artificial Intelligence
Data & Analytics
Digital Health
Healthcare Technology
Software Only

Updated 4 months ago

Funding

Funding not disclosed

LombardstreetNo round attributed

lombardstreet.vc (opens in a new tab)investor website

Funding rounds are not available yet.

Founders

1 founder

Angelica Iacovelli

CEO

Product

Features

Nucleo provides automated AI technology to streamline clinical workflows in oncology care using CT scan analysis. The platform offers automatic quantification of body composition, precise tumor lesion sizing, and lesion classification based on RECIST criteria. This automation accelerates analysis compared to manual segmentation, improving consistency in diagnostic imaging review.